376 related articles for article (PubMed ID: 12704428)
1. Insights into antifolate resistance from malarial DHFR-TS structures.
Yuvaniyama J; Chitnumsub P; Kamchonwongpaisan S; Vanichtanankul J; Sirawaraporn W; Taylor P; Walkinshaw MD; Yuthavong Y
Nat Struct Biol; 2003 May; 10(5):357-65. PubMed ID: 12704428
[TBL] [Abstract][Full Text] [Related]
2. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
3. An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210.
Gaffar FR; Wilschut K; Franssen FF; de Vries E
Mol Biochem Parasitol; 2004 Feb; 133(2):209-19. PubMed ID: 14698433
[TBL] [Abstract][Full Text] [Related]
4. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors.
Nirmalan N; Sims PF; Hyde JE
Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068
[TBL] [Abstract][Full Text] [Related]
5. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
[TBL] [Abstract][Full Text] [Related]
6. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors.
Yuthavong Y; Yuvaniyama J; Chitnumsub P; Vanichtanankul J; Chusacultanachai S; Tarnchompoo B; Vilaivan T; Kamchonwongpaisan S
Parasitology; 2005 Mar; 130(Pt 3):249-59. PubMed ID: 15796007
[TBL] [Abstract][Full Text] [Related]
7. Subunit complementation of thymidylate synthase in Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase.
Chanama M; Chitnumsub P; Yuthavong Y
Mol Biochem Parasitol; 2005 Jan; 139(1):83-90. PubMed ID: 15610822
[TBL] [Abstract][Full Text] [Related]
8. Trypanosomal dihydrofolate reductase reveals natural antifolate resistance.
Vanichtanankul J; Taweechai S; Yuvaniyama J; Vilaivan T; Chitnumsub P; Kamchonwongpaisan S; Yuthavong Y
ACS Chem Biol; 2011 Sep; 6(9):905-11. PubMed ID: 21650210
[TBL] [Abstract][Full Text] [Related]
9. Probing the role of parasite-specific, distant structural regions on communication and catalysis in the bifunctional thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.
Dasgupta T; Anderson KS
Biochemistry; 2008 Feb; 47(5):1336-45. PubMed ID: 18189414
[TBL] [Abstract][Full Text] [Related]
10. Homology modelling of the dihydrofolate reductase-thymidylate synthase bifunctional enzyme of Leishmania major, a potential target for rational drug design in leishmaniasis.
McKie JH
Drug Des Discov; 1994 Jun; 11(4):269-88. PubMed ID: 7727680
[TBL] [Abstract][Full Text] [Related]
11. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
12. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
de Beer TA; Louw AI; Joubert F
Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence.
Eldin de Pécoulas P; Basco LK; Tahar R; Ouatas T; Mazabraud A
Gene; 1998 Apr; 211(1):177-85. PubMed ID: 9573357
[TBL] [Abstract][Full Text] [Related]
15. Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase.
Liang PH; Anderson KS
Biochemistry; 1998 Sep; 37(35):12195-205. PubMed ID: 9724533
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
17. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
[TBL] [Abstract][Full Text] [Related]
18. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
19. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
[TBL] [Abstract][Full Text] [Related]
20. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
Adane L; Patel DS; Bharatam PV
Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
